Latest available resultsQuarter ended July 31, 202610-Q · September 1, 2026
Filed with the SECAGILENT TECHNOLOGIES, INC.
AHealthcare
Next reportNovember 23, 2026after close · Analyst forecast 1.76 $/share
Revenue
$1.88B
▲ +8.1% vs prior year% YoY
Net income
$362.00M
▲ +7.7% vs prior year% YoY
EPS
1.28$
▲ +8.5% vs prior year% YoY
Net margin
19.3%
▼ -0.1 percentage points vs prior year pp YoY
Revenue▲ +8.1 %
Margins (% of revenue)GrossOperatingNet
Net income▲ +7.7 %
EPS▲ +8.5 %
View financial tableQuarter ended July 31, 2026
| Metric | Value | Context |
|---|---|---|
| Operations | ||
| Revenue | $1.88B | |
| Gross profit | $1.04B | 55.5 % |
| Operating income | $444.00M | 23.6 % |
| Net income | $362.00M | 19.3 % |
| R&D | $123.00M | 6.5 % |
| EPS (diluted) | 1.28 $ | |
| Balance sheet | ||
| Assets | $13.97B | |
| Liabilities | $6.60B | |
| Equity | −$233.00M | |
| Cash | $1.76B | |
| Capital | ||
| Shares outstanding | 281.93M | as of 2026-08-26 |
| Public float | — | |